VirtualScopics Inc  

(Public, NASDAQ:VSCP)   Watch this stock  
Find more results for VSCP
4.51
+0.21 (4.88%)
Aug 29 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 4.08 - 4.58
52 week 2.93 - 5.85
Open 4.33
Vol / Avg. 7,892.00/3,543.00
Mkt cap 13.51M
P/E     -
Div/yield     -
EPS -1.11
Shares 2.99M
Beta 1.84
Inst. own 25%
Aug 14, 2014
Q2 2014 VirtualScopics Inc Earnings Call
Aug 14, 2014
Q2 2014 VirtualScopics Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -27.62% -24.56%
Operating margin -27.63% -24.73%
EBITD margin - -21.45%
Return on average assets - -23.25%
Return on average equity - -30.44%
Employees 81 -
CDP Score - -

Address

500 Linden Oaks
ROCHESTER, NY 14625
United States - Map
+1-585-2496231 (Phone)
+1-585-2187350 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

VirtualScopics, Inc. is a provider of quantitative imaging solutions. The Company is serving the pharmaceutical, biotechnology and medical device industries. The Company has created a range of image analysis software tools and applications, which is used in detecting and measuring specific anatomical structures and metabolic activity using medical images. The Company's software and algorithms provide measurement capabilities designed to improve clinical research and development. The Company's image-based measurement and visualization tools enable automated, accurate and reproducible measurement of minute changes that occur in anatomic structures in musculoskeletal, oncological, cardiological and neurological diseases.

Officers and directors

Charles E. Phelps Ph.D. Independent Chairman of the Board
Age: 71
Bio & Compensation  - Reuters
Eric Converse President, Chief Executive Officer, Director
Age: 48
Bio & Compensation  - Reuters
James Groff Chief Financial Officer
Age: 44
Bio & Compensation  - Reuters
Bruce L. Lev Independent Director
Age: 70
Bio & Compensation  - Reuters
David Rubin Ph.D. Independent Director
Age: 49
Bio & Compensation  - Reuters
Terence A. Walts Independent Director
Bio & Compensation  - Reuters